Print

Jul 23, 2013
Yahoo! Finance
PRESS RELEASE

The AIGISRx N Antibacterial Envelope from TYRX, Inc., designed to help reduce infections associated with implantable medical devices, is now FDA-cleared for use with vagus nerve stimulators used to treat seizure disorders and depression. Christopher Rumana, MD, FACS, Clinical Assistant Professor at FSU’s College of Medicine, and Chairman of Tallahassee Memorial Hospital Division of Neurosurgery, is quoted in the article.